Geospiza, the maker of software for biomedical researchers, has raised $750,000 from new and existing angel investors, according to Laura Lucas, vice president of marketing. The company had gained some momentum in the past year, helping scientists cope with information overload of the genomic age. The company secured a $1.1 million grant last month from the National Institutes of Health, and securing new customers at Harvard Medical School and the University of Florida. The news was first reported by TechFlash.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
